Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors. These inhibitors are under investigation for their potential in cancer therapy due to their ability to disrupt NAD+ biosynthesis in tumor cells. The compound’s structure supports derivatization at the carboxamide and dihydropyridone moieties, enabling optimization of potency and selectivity in drug candidates. It is also employed in medicinal chemistry research to explore structure-activity relationships in metabolic pathway modulators.